BioNTech SE (BNTX)
92.30
+0.29
(+0.32%)
USD |
NASDAQ |
May 10, 12:37
BioNTech Shareholders Equity (Quarterly): 21.56B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 21.56B |
December 31, 2023 | 22.38B |
September 30, 2023 | 21.03B |
June 30, 2023 | 21.63B |
March 31, 2023 | 22.10B |
December 31, 2022 | 21.51B |
September 30, 2022 | 18.05B |
June 30, 2022 | 17.58B |
March 31, 2022 | 17.76B |
December 31, 2021 | 13.47B |
September 30, 2021 | 10.10B |
Date | Value |
---|---|
June 30, 2021 | 6.525B |
March 31, 2021 | 2.954B |
December 31, 2020 | 1.687B |
September 30, 2020 | 1.089B |
June 30, 2020 | 676.98M |
March 31, 2020 | 494.26M |
December 31, 2019 | 552.79M |
September 30, 2019 | 455.59M |
June 30, 2019 | 437.17M |
December 31, 2018 | 304.45M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
437.17M
Minimum
Jun 2019
22.38B
Maximum
Dec 2023
11.10B
Average
11.79B
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.28B |
Moderna Inc | 12.82B |
Autolus Therapeutics PLC | 111.47M |
Novavax Inc | -716.93M |
BioVie Inc | 7.491M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 24.04B |
Total Liabilities (Quarterly) | 2.471B |
Debt to Equity Ratio | 0.0118 |
Current Ratio | 11.38 |
Net Debt Paydown Yield | -0.03% |